Report cover image

Transcatheter Embolization and Occlusion Devices Market, By Product, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Publisher AnalystView Market Insights
Published Sep 04, 2025
Length 303 Pages
SKU # ANVM20791050

Description

REPORT HIGHLIGHT

Transcatheter Embolization and Occlusion Devices Market size was valued at US$ 5,493.20 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.
Transcatheter embolization and occlusion devices enable the insertion or passage of a synthetic embolus into the body via a specific body part while utilizing a catheter. Transcatheter embolization is a minimally invasive technique used in interventional radiology to stop blood flow to cancerous tumors. To identify many strategies for targeting tumors, synthetic materials are occasionally used to coat chemotherapeutic medications in order to perform simultaneous acts of blood supply blocking and cytotoxicity.
Transcatheter Embolization and Occlusion Devices Market- Market Dynamics

Increasing demand for minimally invasive techniques fuels market growth.
The growing demand for minimally invasive techniques is expected to drive the growth of the transcatheter embolization and occlusion device market in the near future. Minimally invasive surgeries use small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. Transcatheter embolization and occlusion devices play an important role in these techniques, providing numerous benefits such as reduced invasiveness, shorter recovery times, targeted treatment, less pain, lower complication risks, and the possibility of outpatient procedures. For instance, Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive medical products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, up 18% from about 1,594,000 in 2021. As a result, the growing demand for minimally invasive techniques is a major driver in the transcatheter embolization and occlusion devices market.
Transcatheter Embolization and Occlusion Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2025-2032)
Based on Product segmentation, non-coil was predicted to show maximum market share in the year 2024
On the basis of region, North American was the leading revenue generator in 2024
Transcatheter Embolisation and Occlusion Devices Market- Segmentation Analysis:

The Global Transcatheter Embolisation and Occlusion Devices Market is segmented on the basis of Product and Region.
Two product-based categories comprise the market: Coil and Non-Coil. The non-coil segment will dominate the market with the highest revenue share in 2025, owing to its versatility and effectiveness in a variety of clinical applications. Non-coil devices, such as liquid embolic agents and particle embolization products, provide precise and controlled embolization, which is ideal for treating complex vascular conditions. Their ability to navigate difficult anatomy and provide superior results with minimal complications has earned them high praise among interventional radiologists and surgeons. This growing preference has contributed to the segment's market dominance.
Transcatheter Embolization and Occlusion Devices Market- Geographical Insights

The North American transcatheter embolization and occlusion device market will dominate the global market in 2025. This is due to the increased use of interventional radiology (IR) procedures. Uterine Fibroid Embolization (UFE), a minimally invasive IR procedure, is increasingly popular as a treatment option for symptomatic uterine fibroids. This nonsurgical approach allows for faster recovery and reduces the need for hysterectomy. Rising patient demand for less invasive treatments, combined with increased awareness among healthcare providers, is driving up the use of embolization devices and expanding the market for these innovative solutions. These devices are used to treat atrial fibrillation and varicose veins.
The Asia Pacific transcatheter embolization and occlusion device market is expected to grow the fastest between 2025 and 2032. The growing prevalence of cancer in the region is driving up demand for these devices. They provide effective treatment options for a variety of cancers, including liver and lung cancer, where embolization is an important part of tumor management. Rising healthcare investments are fueling market growth by increasing access to advanced medical technologies and improving healthcare infrastructure. This combination of rising cancer rates and expanding healthcare capabilities is expected to propel the transcatheter embolization and occlusion devices industry forward across the region.
Transcatheter Embolization and Occlusion Devices Market- Competitive Landscape:

The Transcatheter Embolization and Occlusion Devices Market is highly competitive, with Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, and DePuy Synthes (Johnson & Johnson) leading the way. These companies provide a diverse range of innovative devices, such as embolization coils, vascular plugs, and liquid embolic agents, which are frequently integrated with advanced imaging and catheter navigation systems. The competition revolves around technological innovation, miniaturization, and increased safety and efficacy for oncology, neurology, and peripheral vascular procedures.

Recent Developments:

In January 2025, Stryker has agreed to acquire Inari Medical for USD 4.9 billion, expanding its presence in venous thromboembolism care.
In July 2025, Teleflex acquired BIOTRONIK's vascular intervention business for EUR 760 million, expanding its portfolio to include drug-coated balloons and the Freesolve resorbable scaffold.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott
Boston Scientific Corporation
Terumo Corporation
Medtronic
DePuy Synthes (Johnson & Johnson)
Stryker
Cordis
Pfizer Inc.
Sirtex SIR-Spheres Pty Ltd.
Nordion (Canada) Inc.
Others

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Coil
Pushable Coils
Detachable Coils
Non Coil
Flow Diverting Devices
Embolization Particles
Liquid Embolics
Other Embolization and Occlusion Devices
Accessories

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Table of Contents

303 Pages
1. Stroke Rehabilitation Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Stroke Rehabilitation Market Snippet by Treatment Type
2.1.2. Stroke Rehabilitation Market Snippet by Product Type
2.1.3. Stroke Rehabilitation Market Snippet by Stroke Type
2.1.4. Stroke Rehabilitation Market Snippet by End-user Verticals
2.1.5. Stroke Rehabilitation Market Snippet by Country
2.1.6. Stroke Rehabilitation Market Snippet by Region
2.2. Competitive Insights
3. Stroke Rehabilitation Key Market Trends
3.1. Stroke Rehabilitation Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Stroke Rehabilitation Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Stroke Rehabilitation Market Opportunities
3.4. Stroke Rehabilitation Market Future Trends
4. Stroke Rehabilitation Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Stroke Rehabilitation Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Stroke Rehabilitation Market Landscape
6.1. Stroke Rehabilitation Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Stroke Rehabilitation Market – By Treatment Type
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
7.1.2. Devices
7.1.3. Therapy
8. Stroke Rehabilitation Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Electrical Stimulators
8.1.2.1. Table Top
8.1.2.2. Wearable
8.1.3. Robotic Stimulators
8.1.4. Wireless Stimulators
8.1.5. Non-Invasive Stimulators
8.1.6. Cognitive Stimulators
8.1.7. Other Product Types
9. Stroke Rehabilitation Market – By Stroke Type
9.1. Overview
9.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
9.1.2. Ischemic Stroke
9.1.3. Transient Ischemic Attack
9.1.4. Hemorrhagic Stroke
10. Stroke Rehabilitation Market – By End-user Verticals
10.1. Overview
10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Ambulatory Surgical Centers
10.1.4. Long Term Treatment Centers
10.1.5. Specialty Clinics
10.1.6. Home Care Settings
10.1.7. Rehabilitation Centers
10.1.8. Other End User Verticals
11. Stroke Rehabilitation Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Stroke Rehabilitation Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Stroke Rehabilitation Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Stroke Rehabilitation Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Stroke Rehabilitation Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Stroke Rehabilitation Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Stroke Rehabilitation Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Penumbra, Inc. (REAL System)
12.2.2. Shanghai Siyi Intelligent Technology Co., Ltd.
12.2.3. DJO Global.
12.2.4. Saebo Inc
12.2.5. Shenzhen XFT Medical
12.2.6. Soterix Medical Inc.
12.2.7. Restorative Therapies
12.2.8. Zynex Medical, Inc
12.2.9. MYOLYN
12.2.10. ACP - Accelerated Care Plus
12.2.11. Neurosoft
12.2.12. BIONIK Inc
12.2.13. EB Neuro S.p.A
12.2.14. Motorika Medical
12.2.15. Ottobock
12.2.16. Guangzhou Longest Science & Technology Co., Ltd.
12.2.17. Roceso Technologies Pte Ltd
12.2.18. Brain Stimulation AB.
12.2.19. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us